HROW: Multiplikator P/S Harrow Health

Logo korporat perusahaan Harrow Corp (HROW)

Harrow, Inc. is scaling its business through the licensing of dormant patents and direct sales without intermediaries. The GURU.Markets portal features a P/S ratio chart, where 3.50 shows the current value of the metric. The firm's profit relies on the volume of cataract surgeries and prescription manufacturing standards. High surgeon loyalty and advanced logistics strengthen the company's market position in the US.

HROW: Rasio rega marang pendapatan harrowinc.com 04.07.2022 - 13.11.2026

Harrow Health (HROW) - rincian metrik lan laporan keuangan

- rega saham lan konsensus proyeksi valuasi:
Bagan owah-owahan rega harrowinc.com|HROW - Prakiraan konsensus analis
- informasi kapitalisasi pasar:
Kapitalisasi pasar Harrow Health|HROW - Nilai Total Perusahaan
- data ekuitas miturut neraca:
Nilai Akuntansi Saham Harrow|HROW - Nilai Buku Perusahaan|Nilai Pasar marang Nilai Buku harrowinc.com|HROW - Aset Agregat Perusahaan
- indikator beban kredit lan likuiditas emiten:
Utang marang Modal Harrow, Inc.|HROW - Rasio utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang ekuitas Harrow Corp|HROW - Gunggung utang perusahaan|Rasio utang marang aset resik Harrow Health|HROW - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak Harrow|Rasio likuiditas darurat harrowinc.com
- informasi bathi lan kelipatan valuasi:
HROW - Bathi resik|Bathi mangsa ngarep Harrow, Inc.|HROW - Koefisien rega marang bathi|Kapitalisasi marang proyeksi bathi Harrow Inc|HROW - Pangali PEG|Nilai bisnis marang bathi operasional sadurunge panyusutan Harrow Health|HROW - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajroning taun lumaku Harrow|HROW - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan harrowinc.com|HROW - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi saben saham kanggo taun ngarep Harrow, Inc.
- data total pendapatan lan volume dodolan:
HROW - Pendapatan perusahaan|Pendapatan sing dikarepake perusahaan harrowinc.com|HROW - Multiplikator P/S|Rega forward marang dodolan Harrow Health
Ringkesan analitik perusahaan:harrowinc.com, HROW
Produk seri Harrow, Inc.

The P/S ratio reflects the market value of Harrow, Inc. (HROW) relative to its revenue, where the calculated P/S allows for an assessment of the premium for business quality or the risk of overvaluation. This indicator correlates market capitalization with revenues from unique ophthalmological drugs, confirming the resilience of the model through strict adherence to medical protocols and stable demand from surgeons.

Perusahaan pesaing

ALC (alcon.com) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S BLCO (Bausch + Lomb)|Multiplikator P/S Glaukos Corp GKOS|APLS - Rasio rega marang pendapatan|Rasio kapitalisasi pasar marang pendapatan BLTE (Belite Bio, Inc)|Ocular Therapeutix (OCUL) - Rasio rega marang pendapatan|viridiantherapeutics.com - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan LENZ Therapeutics|Rega marang dodolan Oculis Holding OCS|Kapitalisasi marang pendapatan EYPT (EyePoint Pharma)|Kapitalisasi marang pendapatan Kodiak Corp KOD|Aldeyra Therapeutics, Inc. - Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan KALA|Opus Bio - Multiplikator P/S|Koefisien rega marang pendapatan OKYO Pharma Limited OKYO|adverum.com (ADVM) - Rasio rega marang pendapatan|Rasio kapitalisasi marang pendapatan OTLK|CLSD (Clearside Biomedical) - Multiplikator P/S|Kapitalisasi marang pendapatan NovaBay (NBY)|Kapitalisasi marang pendapatan KPRX (Kiora Pharmaceuticals)|Koefisien rega marang pendapatan alimerasciences.com|Multiplikator P/S EYEN (Eyenovia)|Rasio kapitalisasi pasar marang pendapatan GHSI|OCUP - Rasio rega marang pendapatan|Rasio kapitalisasi pasar marang pendapatan OPT (opthea.com)